FDA Approves GARDASIL(R) For Use In Boys And Young Men

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for use in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. FDA approval is the first step in an important two-step process.



Sponsored by Indian Pharmacy, an Internet Pharmacy - online pharmacy supplies more than 600 high quality generic medications, at discounted prices, worldwide shipping.
xanax

Canadian Pharmacy the only canadian pharmacy offers Brand Hydrocodone Watson 540 and Oxycodone

Related posts:

  1. FDA Approves New Indication For Gardasil To Prevent Genital Warts In Men And Boys
  2. FDA Advisory Committee Recommends Approval For Use Of GARDASIL(R) In Boys And Men
  3. CDC Panel Recommends HPV Vaccine Cervarix For Girls, Optional Gardasil Vaccination For Boys


canadian pharmacy